GlassScriptPhysician profile
Robin M Taylor
NPI 1972863165
$4,112.33
in general payments reported to CMS, 2019-2025
38 companies · $867 in 2025
The $867 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.58 · 2020: $450 · 2021: $778 · 2022: $804 · 2023: $436 · 2024: $765 · 2025: $867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,068.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $689.13 | 2020-2025 | Lo Loestrin Fe, Orilissa |
| Novo Nordisk INC | $423.97 | 2020-2025 | Wegovy |
| Sumitomo Pharma America, INC. | $336.64 | 2023-2025 | Myfembree |
| Daiichi Sankyo INC. | $322.34 | 2020-2025 | Injectafer |
| Biogen, INC. | $224.00 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $201.72 | 2022-2025 | |
| Hologic Sales and Service, LLC | $199.17 | 2021-2025 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Myovant Sciences INC. | $181.52 | 2021-2022 | |
| Shield Therapeutics INC | $177.11 | 2024-2025 | |
| Astellas Pharma US INC | $175.07 | 2025 | Veozah |
| Pfizer INC. | $160.83 | 2023-2025 | |
| Exeltis, USA INC. | $152.06 | 2020-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $121.15 | 2020-2025 | |
| Coopersurgical, INC. | $85.92 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Mylan Pharmaceuticals INC. | $51.67 | 2020-2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.